contact

MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

HEMOBLAST™ Bellows IN THE OPERATING ROOM

HEMOBLAST™ Bellows, DEVELOPPED BY AND FOR SURGEONS

Since end of 2016, HEMOBLAST™ Bellows has been extensively evaluated across several centers in France and Germany.
This premarket evaluation (PME) provides relevant data on HEMOBLAST™ Bellows use in the clinical settings from expert surgeons in cardiovascular, abdominal and spine surgeries.

94%

of surgeons who tried HEMOBLAST™ Bellows were satisfied with the powder application on the target site(1)*

93%

of surgeons who tried HEMOBLAST™ Bellows were satisfied with how it performed and would recommend that their hospitals buy it(1)

83%

of surgeons stated HEMOBLAST™ Bellows could replace another hemostatic agent(1)

DISCOVER CLINICAL CASES

Abdominal surgery

Cardiovascular surgery

Hepatic surgery

Spine surgery

* Including 65% “Very satisfied” and 29% “Satisfied”.
1. Biom’up, internal data. Data derived from clinical use of 186 cases with 75 surgeons in Germany and France (PME report).

Legal Information: Biom’Up France SAS is a distributor of HEMOBLAST™ Bellows - Implantable Medical device Class III for surgery reserved for use by qualified healthcare professionals, reimbursement depends on each country. Read the instructions for use on the packaging carefully before use. Manufacturer: Biom’up SA.

Sitemap